James J Manfredi (J J Manfredi)

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 7

Top Topics

Childhood Cancer

Municipal Solid Waste

Top Venues

Molecular cancer research : MCR

The EMBO journal

This page only lists publications with an associated author ORCID identifier.

Publications

Gizem Efe, Karen J Dunbar, Kensuke Sugiura, Katherine Cunningham, Saul Carcamo, Spyros Karaiskos, Qiaosi Tang, Ricardo Cruz-Acuna, Lois Resnick-Silverman, Jessica Peura, Andrew O M Wilkie, Dan Hasson, Andres J Klein-Szanto, Alison M Taylor, James J Manfredi, Carol Prives, Anil K Rustgi
p53 gain-of-function mutation induces metastasis via Brd4-dependent Csf-1 expression. Cancer discovery (2023)
Zhenyi Su, Ning Kon, Jingjie Yi, Haiqing Zhao, Wanwei Zhang, Qiaosi Tang, Huan Li, Hiroki Kobayashi, Zhiming Li, Shou-Fu Duan, Yanqing Liu, Kenneth P Olive, Zhiguo Zhang, Barry Honig, James J Manfredi, Anil K Rustgi, Wei Gu
Specific regulation of BACH1 by the hotspot mutant p53 R175H reveals a distinct gain-of-function mechanism. Nature cancer (2023)
Kelvin César de Andrade, Elaine E Lee, Elise M Tookmanian, Chimene A Kesserwan, James J Manfredi, Jessica N Hatton, Jennifer K Loukissas, Jiri Zavadil, Lei Zhou, Magali Olivier, Megan N Frone, Owais Shahzada, William J R Longabaugh, Christian P Kratz, David Malkin, Pierre Hainaut, Sharon A Savage
The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute. Cell death and differentiation 29 (5) (2022)
James J Manfredi
Mdm2 and MdmX: Partners in p53 Destruction. Cancer research 81 (7) (2021)
David R Tong, Wen Zhou, Chen Katz, Kausik Regunath, Divya Venkatesh, Chinyere Ihuegbu, James J Manfredi, Oleg Laptenko, Carol Prives
p53 Frameshift Mutations Couple Loss-of-Function with Unique Neomorphic Activities. Molecular cancer research : MCR 19 (9) (2021)
Marina Farkas, Hideharu Hashimoto, Yingtao Bi, Ramana V Davuluri, Lois Resnick-Silverman, James J Manfredi, Erik W Debler, Steven B McMahon
Distinct mechanisms control genome recognition by p53 at its target genes linked to different cell fates. Nature communications 12 (1) (2021)
James J Manfredi
p53 defies convention again: a p53 mutant that has lost tumor suppression but still can kill. The EMBO journal 38 (20) (2019)
S K Mungamuri, S Wang, James J Manfredi, W Gu, S A Aaronson
Ash2L enables P53-dependent apoptosis by favoring stable transcription pre-initiation complex formation on its pro-apoptotic target promoters. Oncogene 34 (19) (2014)